Indeed, OPA1 patients displayed the clinical profile of auditory neuropathy (AN) consisting of moderate hearing loss with disproportionate impairment of speech perception, abnormal brainstem responses and presence of normal otoacoustic emissions (OAE) (Starr et al., 1996). The gene discussed is OPA1; the disease is auditory neuropathy.